Immunotherapy tablet helps control asthma in people with house dust mite allergy
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2358 (Published 27 April 2016) Cite this as: BMJ 2016;353:i2358- Jacqui Wise
- London
Patients with house dust mite allergy related asthma showed improvements in asthma control when given sublingual allergen immunotherapy on top of their usual medicine, research published in JAMA has found.1
Sublingual allergen immunotherapy involves small doses of an allergen contained in a soluble tablet placed under the tongue. In this case the tablet contained extracts from two species of cultivated house dust mite. House dust mite sensitisation is present in as many as half of patients with asthma, and exposure to the house dust mite allergen …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.